Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
Objectives Immune checkpoint inhibitors (ICPi) have significantly improved survival for patients with advanced cancers. However, the occurrence of ICPi-associated acute kidney injury (AKI) and its clinical impact remains unclear. This study evaluates the effects of ICPi-associated AKI (ICPi-AKI) on...
Saved in:
Main Authors: | Vin-Cent Wu, Ting-Ya Yang, Min-Hsiang Chuang, Hong-Min Lin, Heng-Chih Pan, Yun Chou, Jui-Yi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/2/e092752.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
by: Yuhui Yang, et al.
Published: (2025-02-01) -
A case of immune checkpoint inhibitor-related conjunctivitis controlled by tacrolimus eye drops
by: Ayaka Kawaguchi, et al.
Published: (2025-03-01) -
The clinical characteristics and implications of acute kidney injury during induction therapy for acute promyelocytic leukemia
by: Kai Shen, et al.
Published: (2025-02-01) -
Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors
by: Yan Li, et al.
Published: (2025-02-01) -
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
by: Jeanne Shen, et al.
Published: (2024-02-01)